[Current trends in coronary angioplasty]

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology

Background:

• Coronary angioplasty is a rapidly evolving field.
• Balloon angioplasty and bypass surgery demonstrate comparable mid-term mortality and complication rates, as supported by BARI trial data.
• Balloon angioplasty is associated with a high reintervention rate and is not advised for diabetic patients with multivessel disease.

Purpose of the Study:

• To review the current status and advancements in coronary angioplasty.
• To evaluate the efficacy of coronary stents and adjunctive therapies.
• To discuss the clinical impact of novel interventional devices and techniques.

Main Methods:

• Review of clinical trial data and published literature on coronary angioplasty.
• Analysis of outcomes comparing balloon angioplasty, bypass surgery, and percutaneous transluminal coronary angioplasty (PTCA).
• Evaluation of the role of coronary stents, antiplatelet agents, and GP IIb/IIIa inhibitors.

Main Results:

• Balloon angioplasty and bypass surgery are equivalent for mortality and major complications in mid-term follow-up.
• Direct PTCA's superiority over thrombolytic therapy for acute myocardial infarction remains debated.
• Coronary stents have expanded their role, with antiplatelet agents (e.g., ticlopidine) reducing subacute stent thrombosis.
• GP IIb/IIIa inhibitors facilitate more aggressive interventional strategies for acute coronary syndromes.

Conclusions:

• Coronary angioplasty continues to advance, with stents and antiplatelet therapies significantly improving safety and efficacy.
• While effective, balloon angioplasty necessitates frequent reinterventions.
• Emerging technologies like laser angioplasty and local drug delivery have minimal current clinical impact.